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 In Table S1, the sequence of zfZMYND8MO should read GCCATCTTGGCCTCCTCATGTCCAT. Moreover, instead of ‘zfVEGFAb MO’ the term
‘zfVEGFAa MO’ should have been used.
 In the Results subsection ‘3.2. ZMYND8 regulates tumour angiogenesis in DU145-xenografted Zebraﬁsh’, the phrase ‘co-injection of
vegfab MO (zfVEGFAb MO) as the positive control’ should be changed to ‘co-injection of vegfaa MO (zfVEGFAa MO) as the positive
control’.
 In Figs. S3 and S4, the term ‘zfVEGFAb MO’ should be replaced by the term ‘zfVEGFAa MO’.
The authors apologize for these mistakes.chool of
